Recent reforms on price transparency will substantially increase payers’ workloads. The Trump administration and CMS recently released a final rule that will require payers to post documents that include in-network and out-of-network provider rates and in-network drug prices starting in 2022. And in 2023, private insurers will be required to provide negotiated provider cost-sharing estimates and up-front prices to members.

The AJMC interviews Precision’s Kellie Rademacher about the benefits and challenges of the rule.

See the full interview here